| # | Ticker | Signal | Industry | Score (100) | Q+E+S+B | Price | Change | RSI | 3yr High |
|---|---|---|---|---|---|---|---|---|---|
| 1 | HPE27 | π MONITOR | Computer & Office Equipment | 71 π | (48+4+9+10) | $55.22 | -4.5% | 54 | $59.82 |
| 2 | CDNA6 | π MONITOR | Medical Laboratories | 69 π | (59+0+10+0) | $50.02 | +1.7% | 62 | $52.36 |
| 3 | AVT3 | π MONITOR | Electronic Parts - Wholesale | 66 π | (54+4+8+0) | $92.97 | +1.8% | 55 | $98.63 |
| 4 | CON17 | π MONITOR | Specialty Outpatient Facilit... | 65 | (56+0+9+0) | $34.24 | -1.2% | 55 | $35.53 |
| 5 | LTC | π MONITOR | REITs | 64 | (54+0+10+0) | $42.50 | -1.1% | 64 | $42.81 |
π SPOTLIGHT | β OPPORTUNITY | π MONITOR
|
Daily Gainers
|
Daily Losers
|
How much each stock moved from its opening price to its closing price on 2026-09-10, among the stocks that passed our Stage 1 screen. This is not a market-wide list.
π’ What they do: Paysign, Inc. is a payments technology company that provides prepaid card programs, integrated payment processing, and digital banking/payment solutions for businesses, healthcare and pharmaceutical clients, and government or consumer payout programs.
- π― Current $13.34 is 6% below 3yr high $14.14 Β· β³ SMA200 $6.71 (current price $13.34 is above) Β· π° Market Cap $753M
- PAYS shows decent technicals supported by positive sentiment.
π Quality (Q): 53/60
- π¦ EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 450% (>20%); Revenue growth 48% (>15%); ROE 26% (>15%); Low LT D/E 0.06 (<1.0).
β° Entry (E): 0/20
- π Strong above EMA50 (18.4%)
- π VWMA trending up (5 consecutive days)
- π RSI at 61 showing strength
π’ Sentiment (S): 9/10
- ποΈ News sentiment is positive.
β
Paysign (PAYS) Stock Gets Fair Value Boost After Q2 And Guidance ... β Yahoo Finance.
π€ The article reports that Barrington raised its Paysign price target twice in August, ultimately to $11, following Q2 results and guidance. Higher valuation targets tied to operating performance are a positive catalyst for PAYS.
β
Paysign Targets $117M Revenue as Patient-Affordability Business Surges β MarketBeat.
π€ Paysign's patient-affordability business is reported as surging, alongside a revenue target of up to $117 million. Strong growth in an expanding business line and elevated revenue expectations are positive for PAYS.
βͺοΈ Paysign: Growth In Both Segments, But Guidance Implies Lower H2 ... β Seeking Alpha.
π€ The analysis recognizes growth in both the plasma-payments and patient-affordability segments, but flags that company guidance points to a slower second half. The mixed fundamental assessment is neutral for the shares.
π Bonus (B): 0/10 β Business Services
π’ What they do: MISTRAS Group provides technology-enabled industrial asset integrity and asset protection solutions, including non-destructive testing, inspection, monitoring, and engineering services. It also offers related testing products, systems, and software for critical infrastructure and industrial assets.
- π― Current $19.35 is 3% below 3yr high $19.98 Β· β³ SMA200 $15.78 (current price $19.35 is above) Β· π° Market Cap $616M
- MG shows decent technicals supported by positive sentiment.
π Quality (Q): 45/60
- π¦ EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 130% (>20%); Low LT D/E 0.72 (<1.0); PEG ratio 0.18 (<1.5).
β° Entry (E): 0/20
- π VWMA trending up (5 consecutive days)
π’ Sentiment (S): 10/10
- ποΈ News sentiment is positive.
β
MISTRAS Group Expands U.S. Footprint to Serve Growing Industrial Markets β GlobeNewswire.
π€ MISTRAS announced several new field-service locations in key U.S. industrial markets, expanding its customer reach and operating footprint. The expansion suggests potential long-term growth in demand and revenue.
β
Mistras Group Opens Five New US Locations β Yahoo Finance.
π€ The company opened five new U.S. field-service locations to broaden its service coverage. This supports a constructive outlook for customer acquisition and future growth.
β
MISTRAS Group Accelerates AI and Digital Innovation Strategy β GlobeNewswire.
π€ MISTRAS announced an accelerated artificial-intelligence strategy and appointed an executive director of AI. The initiative could improve the companyβs technology capabilities, data monetization, and competitive position.
π Bonus (B): 0/10 β Engineering Services
π’ What they do: Hewlett Packard Enterprise (HPE) is an enterprise technology company that provides compute, storage, networking, and software solutions designed for hybrid IT environments and AI infrastructure.
- π― Current $55.22 is 8% below 3yr high $59.82 Β· β³ SMA200 $33.54 (current price $55.22 is above) Β· π° Market Cap $73.3B
- HPE shows decent technicals supported by positive sentiment.
π Quality (Q): 48/60
- π¦ EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 405% (>20%); Revenue growth 34% (>15%); Low LT D/E 0.82 (<1.0); PEG ratio 0.07 (<1.5).
β° Entry (E): 4/20
- π RSI at 54 in healthy mid-range
π’ Sentiment (S): 9/10
- ποΈ News sentiment is positive.
β
Hewlett Packard Enterprise (NYSE:HPE) Upgraded to Strong-Buy at Wall Street Zen β MarketBeat.
π€ Wall Street Zen upgraded HPE from buy to strong-buy, which is a bullish analyst signal. The article also highlights HPE's strong prior-quarter beat, with adjusted EPS and revenue both above estimates.
β
Hewlett Packard Enterprise Co. stock outperforms competitors on strong trading day β MarketWatch.
π€ HPE shares rose 5.12% on the day, indicating favorable trading momentum. The item is brief and does not identify a new fundamental catalyst, but the price action itself is supportive.
βͺοΈ BNP Paribas Trims Holdings in Hewlett Packard Enterprise ... β MarketBeat.
π€ This is mainly a routine institutional holdings disclosure, which is neutral by rule. The article contains no new company catalyst beyond reiterating HPE's prior earnings beat and guidance.
π Bonus (B): 10/10 β Computer & Office Equipment (Technology sector)
π’ What they do: CareDx, Inc. is a precision medicine company focused on transplant patients. It develops diagnostics, digital health tools, lab products, and patient support services to help monitor care before and after organ transplantation.
- π― Current $50.02 is 4% below 3yr high $52.36 Β· β³ SMA200 $25.51 (current price $50.02 is above) Β· π° Market Cap $2.6B
- CDNA shows decent technicals supported by positive sentiment.
π Quality (Q): 59/60
- π¦ Low drawdown (12.3% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 1394% (>20%); Revenue growth 52% (>15%); ROE 26% (>15%).
β° Entry (E): 0/20
- π Strong above EMA50 (17.3%)
- π VWMA trending up (5 consecutive days)
- π RSI at 62 showing strength
π’ Sentiment (S): 10/10
- ποΈ News sentiment is positive.
β
CareDx (NASDAQ:CDNA) Earns Buy Rating from Analysts at Canaccord Genuity Group β MarketBeat.
π€ Canaccord Genuity initiated coverage of CareDx with a Buy rating and a $65 price target, implying material upside from the cited share price. This is a favorable analyst catalyst for CDNA.
π Bonus (B): 0/10 β Medical Laboratories
π’ What they do: Avnet, Inc. is a global distributor of electronic components and a technology solutions provider that supports engineers, entrepreneurs, and startups in taking tech projects from idea and design to prototype and mass production.
- π― Current $92.97 is 6% below 3yr high $98.63 Β· β³ SMA200 $71.82 (current price $92.97 is above) Β· π° Market Cap $7.6B
- AVT shows decent technicals supported by positive sentiment.
π Quality (Q): 54/60
- π¦ Low drawdown (12.5% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 1578% (>20%); Revenue growth 48% (>15%); Low LT D/E 0.39 (<1.0).
π’ Sentiment (S): 8/10
- ποΈ News sentiment is positive (mixed coverage).
β
Avnet (AVT) Lifts Dividend After Buybacks And Growth ... β Yahoo Finance.
π€ Avnetβs board approved a 5.7% increase in the quarterly dividend to $0.37 per share. The higher payout signals shareholder-return support and confidence in the companyβs cash generation.
β
Avnet Increases Quarterly Dividend by 5.7% β Yahoo Finance.
π€ Avnet raised its quarterly dividend from $0.35 to $0.37 per share. The increase is a favorable shareholder-return action and suggests management remains comfortable with the companyβs financial position.
β Why Is Avnet (AVT) Down 6.2% Since Last Earnings Report? β Yahoo Finance.
π€ The article reports that Avnet shares declined approximately 6.2% since the latest earnings release, underperforming the S&P 500. This reflects weak recent share-price momentum despite the companyβs reported earnings beat.
π Bonus (B): 0/10 β Electronic Parts - Wholesale
π’ What they do: Concentra Group Holdings Parent, Inc. is a provider of occupational health services in the United States, focused on helping employers manage workplace injuries and employee health. Its services include occupational health centers, onsite employer clinics, telemedicine, workersβ compensation care, and other direct-to-employer health services.
- π― Current $34.24 is 4% below 3yr high $35.53 Β· β³ SMA200 $25.34 (current price $34.24 is above) Β· π° Market Cap $4.4B
- CON shows decent technicals supported by positive sentiment.
π Quality (Q): 56/60
- π¦ Low drawdown (8.4% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 46% (>20%); ROE 42% (>15%); Low LT D/E 0.00 (<1.0).
β° Entry (E): 0/20
- π VWMA trending up (5 consecutive days)
- π RSI at 55 in healthy mid-range
π’ Sentiment (S): 9/10
- ποΈ News sentiment is positive.
β
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Concentra Group Holdings Parent (NYSE:CON) Stock β MarketBeat.
π€ JPMorgan raised its price target for CON from $34 to $43 while maintaining an Overweight rating, implying substantial upside and providing a positive analyst catalyst.
β
Concentra Group Holdings Parent (NYSE:CON) Upgraded by Zacks Research to Strong Buy Rating β MarketBeat.
π€ Zacks upgraded CON from Hold to Strong Buy, signaling improved analyst sentiment and potentially supporting the stock price.
βͺοΈ Concentra Appoints Dr. Jill Rosenthal as Chief Medical Officer to Advance Clinical Innovation and Workforce Health β Business Wire.
π€ Concentra announced the appointment of Dr. Jill Rosenthal as chief medical officer. The leadership appointment may support clinical and workforce-health initiatives, but the available report does not identify a direct near-term financial impact.
π Bonus (B): 0/10 β Specialty Outpatient Facilities
π’ What they do: LTC Properties, Inc. is a real estate investment trust (REIT) focused on senior housing and healthcare properties in the United States. It invests in and leases properties such as skilled nursing facilities, assisted living communities, and memory care facilities to healthcare operators.
- π― Current $42.50 is 1% below 3yr high $42.81 Β· β³ SMA200 $38.08 (current price $42.50 is above) Β· π° Market Cap $2.3B
- LTC shows decent technicals supported by positive sentiment.
π Quality (Q): 54/60
- π¦ Low drawdown (12.7% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 75% (>20%); Revenue growth 64% (>15%); Low LT D/E 0.61 (<1.0).
β° Entry (E): 0/20
- π VWMA trending up (5 consecutive days)
- π RSI at 64 showing strength
π’ Sentiment (S): 10/10
- ποΈ News sentiment is positive.
β
Huntington Begins Coverage on LTC Properties (NYSE:LTC) β MarketBeat.
π€ Huntington initiated coverage with an Outperform rating and a $47 price target, implying roughly 10.4% upside from the reported share price. The new bullish analyst coverage reinforces the stockβs broadly positive consensus rating.
β
LTC Properties (NYSE:LTC) Reaches New 1-Year High - Time to Buy? β MarketBeat.
π€ LTC reached a new 52-week high, while the article highlighted the companyβs earnings beat, strong year-over-year revenue growth, monthly dividend, and Moderate Buy analyst consensus. These factors are supportive of investor sentiment, although the price strength may also indicate some optimism is already reflected.
β
LTC (LTC) Completed a $200M Senior-Housing Acquisition. Can Higher Operating Exposure Beat the Income It Divested? β Yahoo Finance.
π€ LTC completed a $200 million acquisition of four senior-housing operating communities in Minnesota, increasing exposure to operating assets. The transaction could support growth and operating income, though it also introduces greater execution and operating risk.
π Bonus (B): 0/10 β REITs
The following categories are excluded from our screening universe (with a few whitelisted exceptions):
Actionable and freshly screened US πΊπΈ stocks in your inbox every trading day.